Rytary ER 36.25 MG-145 MG cap 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FXNN0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,385
Award facts
- Contract value 100% obligated
- $11,384.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,384.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in quantities of 100 count on November 26, 2025, with completion scheduled for November 28, 2025. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
RYTARY ER is a neurological medication used in the treatment of Parkinson's disease, reflecting the Defense Logistics Agency's responsibility for procuring specialized pharmaceuticals to support military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio with DLA, regularly delivering brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle enables AmerisourceBergen to supply pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, supporting both domestic and global military medical operations.
Quick answers
Who was awarded contract SPE2DR26FXNN0?
SPE2DR26FXNN0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FXNN0 worth?
The government has obligated $11,385 on SPE2DR26FXNN0.
Is contract SPE2DR26FXNN0 an order under another contract?
Yes. SPE2DR26FXNN0 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXNN0 competed?
The extent of competition for SPE2DR26FXNN0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award